Wed, Apr 16, 2014, 5:46 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

lokodaug 1 post  |  Last Activity: Mar 26, 2014 10:46 AM Member since: Mar 26, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • For details, suggest you read the post on Mark's new Antares article.

    From years of research it is highly probable these will be the first two ATRS/Teva Pen Products.

    So Loko's Final Speculative.."Affordable Combo Adjustable Drug" ACA list on Teva/Anatares injector combo for Pen #1 and Pen#2 Products are as follows.

    Pen#1 = "Multiple Dosage Injector," patent # 8376993 initial drug follitropin, (Oavaleap)......... future drugs will be Teriparatide and Exenatide

    Pen#2 = "Injector with Adjustable Dosing" the last public filing is US20090299278, the initial drug will be tbo-filgrastim (Granix), and it will be call "Egranli" injector.

    End of Story and job is done here... told the Pen #1 and #2 Product story...........Not that Loko will ever get credit for the effort, just like METEX PEN Story...

    So say whatever you want, trash, bash, or be at awe, Loko's job is done here and will not be posting any more. The fake phony evil stalker, or whomever can do what they want ........cause Adioski.....

    So it is all tappy and all of his buddies all the time......

    Sadly, Loko can not say it's been fun.... but certainly educational.....

    Thanks for nothing....and this is the only Stinky Poo Post Loko leaves for years of effort...

    Loko's rein of terror is over.....Say bye to the gang Jack....

    Loko, The Greatest of the Greats... well actually the only Great the others are all fakes........

30.09+0.20(+0.67%)Apr 16 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.